Clinical trials
Phase 2 Brain Diseases trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 3 |
| Completed | 2 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| MapLight Therapeutics | 2 |
| Affiris AG | 1 |
| Alkahest, Inc. | 1 |
| Genentech, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Inmune Bio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Diseases | 7 |
| Dementia | 7 |
| Alzheimer Disease | 6 |
| Mental Disorders | 6 |
| Nervous System Diseases | 6 |
| Neurodegenerative Diseases | 6 |
| Central Nervous System Diseases | 5 |
| Neurocognitive Disorders | 5 |
| Tauopathies | 4 |
| Hallucinations | 2 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.